Maury Raycroft

Stock Analyst at Jefferies

(0)
# 4784
Out of 5,340 analysts
78
Total ratings
22.22%
Success rate
-21.75%
Average return
Main Sectors:
Top Industries:
41 Stocks
Name Action PT Current % Upside Ratings Updated
CRBP Corbus Pharmaceutica...
Maintains: Buy
70 53
7.33 623.06% 2 Mar 11, 2025
CMRX Chimerix
Downgrades: Hold
10 9
n/a n/a 2 Mar 5, 2025
CMPX Compass Therapeutics
Maintains: Strong Buy
7 8
2.1 280.95% 2 Feb 10, 2025
SGMO Sangamo Therapeutics
Maintains: Buy
7 3
0.47 538.3% 1 Dec 31, 2024
MREO Mereo BioPharma Grou...
Initiates Coverage On: Buy
7
2.23 213.9% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.29 365.12% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Strong Buy
16 17
3.96 329.29% 1 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
1.5 1166.67% 1 Jul 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
58 39
n/a n/a 2 May 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
23 15
1.59 843.4% 1 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 39
19.64 98.57% 2 Mar 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
0.74 710.81% 1 Mar 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
1.67 1277.25% 1 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
195
6.84 2750.88% 1 Feb 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
55 58
n/a n/a 7 Oct 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
11
10.24 7.42% 8 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
104 173
n/a n/a 3 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
4 2
n/a n/a 1 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
6 9
0.33 2627.27% 2 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
32 6
21.23 -71.74% 2 Jan 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
92 75
15.7 377.71% 4 Nov 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 36
n/a n/a 2 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
218 232
285.13 -18.63% 1 Oct 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
3.56 208.99% 1 Sep 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 20
n/a n/a 1 Sep 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
39 55
n/a n/a 1 Apr 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
31 27
9.93 171.9% 3 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
38 5
1.66 201.2% 2 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
12 17
n/a n/a 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
n/a n/a 1 Nov 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
48
10.65 350.7% 1 Sep 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
320
n/a n/a 1 Jul 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
6.27 474.16% 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
105
2.75 3718.18% 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
172
38.79 343.41% 2 Apr 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
n/a n/a 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
47
1.97 2285.79% 1 Feb 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 2
n/a n/a 2 Jan 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
18 40
0.28 14185.71% 5 Aug 28, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
230
4.08 5537.25% 1 Jul 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 42
8.49 394.7% 3 Nov 1, 2017